First, Limin Health Group "2020 China Great Health Industry Outstanding Contribution Award"
The 2020 China Great Health Industry Outstanding Contribution Award, which received much attention this annual meeting week, was announced. The selection targets are mainly outstanding enterprises, institutions, products and leading figures who have made outstanding achievements in the field of big health. After professional selection and online voting, Limin Health Group won the "2020 W China Great Health Industry Outstanding Contribution Award". Li Ming, president of Limin Health Group, said in a speech at the roundtable forum on "How the Internet empowers medical care" that Limin Health Group has been committed to promoting the reform of China's health care service model with innovative technologies. Through the application of innovative scientific and technological means such as artificial intelligence, big data and genetic testing, we will continuously improve the quality and efficiency of medical services and provide quality health management services throughout the life cycle.
Second, "internet plus" empowers medical health "
Limin Health Group has been committed to using innovative technology to drive the reform of China's health care service model. Through the application of innovative technologies such as artificial intelligence, big data and genetic testing, the quality and efficiency of medical services will be continuously improved, and high-quality health management services will be provided throughout the life cycle. Before the emergence of AI, there were 40,000 ophthalmologists in China with a population of 654.38+0.4 billion, and only about 6,543.8+0,000 ophthalmologists could see the fundus. Airdoc artificial intelligence retinal imaging technology introduced by Limin Health Group can not only check the risk of fundus diseases and chronic diseases, but also find brain tumors through fundus photos. The core of precision medicine is to do genetic testing. Take colorectal cancer as an example. Although the incidence of colorectal cancer is high, it is very suitable for early screening. Limin Health Group launched a multi-target fecal FIT-DNA detection product-Nuohui Healthy Changweiqing, which was developed according to the genome characteristics of China population, and obtained the first cancer early screening certificate in China.
For a long time, Limin Health Group has been committed to health management, improving the quality of life, driving the reform of health care service model with innovative technology, and has never stopped on the road of exploring innovative health management service model. We have been at the forefront of the application of artificial intelligence and big data in the field of preventive medicine, providing high-quality health management services for Chinese people and fulfilling the duties of "health gatekeeper".